Total Payments
$4,206
2022 Payments
$501.28
Companies
32
Transactions
232
Medicare Patients
1,130
Medicare Billing
$187,736
Payment Breakdown by Category
Food & Beverage$4,165 (99.0%)
Education$40.69 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,165 | 230 | 99.0% |
| Education | $40.69 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $976.48 | 47 | $0 (2022) |
| GlaxoSmithKline, LLC. | $890.44 | 59 | $0 (2022) |
| Amgen Inc. | $366.08 | 14 | $0 (2022) |
| ABBVIE INC. | $235.57 | 15 | $0 (2022) |
| Amarin Pharma Inc. | $207.21 | 10 | $0 (2021) |
| Abbott Laboratories | $201.24 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $147.54 | 10 | $0 (2021) |
| Allergan, Inc. | $115.93 | 5 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $113.22 | 7 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $112.58 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $501.28 | 29 | ABBVIE INC. ($122.33) |
| 2021 | $708.58 | 37 | GlaxoSmithKline, LLC. ($186.14) |
| 2020 | $795.47 | 40 | GlaxoSmithKline, LLC. ($242.88) |
| 2019 | $560.47 | 22 | Amarin Pharma Inc. ($146.96) |
| 2018 | $864.29 | 45 | GlaxoSmithKline, LLC. ($203.40) |
| 2017 | $775.63 | 59 | AstraZeneca Pharmaceuticals LP ($214.53) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/27/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 07/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 05/16/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes Care | ||||||
| 05/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Gastroenterology | ||||||
| 04/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 03/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $71.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes Care | ||||||
| 03/10/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: UROLOGY | ||||||
| 03/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2022 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Respiratory | ||||||
| 02/02/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 165 | 415 | $96,093 | $29,403 |
| 2021 | 8 | 299 | 1,055 | $218,416 | $86,433 |
| 2020 | 9 | 666 | 1,464 | $230,896 | $71,901 |
Total Patients
1,130
Total Services
2,934
Medicare Billing
$187,736
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 362 | $83,608 | $26,113 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $6,172 | $1,834 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,314 | $1,456 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 892 | $198,492 | $79,379 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 51 | $9,182 | $3,217 | 35.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,525 | $1,543 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 14 | $1,197 | $830.78 | 69.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $727.65 | $717.86 | 98.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 25 | 29 | $2,318 | $285.93 | 12.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 23 | 30 | $826.71 | $257.02 | 31.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $1,147 | $203.19 | 17.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 186 | 709 | $155,952 | $42,769 | 27.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 142 | 282 | $22,708 | $15,959 | 70.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 117 | 181 | $11,539 | $6,429 | 55.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 162 | $28,855 | $5,111 | 17.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 18 | 22 | $6,867 | $715.72 | 10.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 48 | 50 | $3,200 | $347.84 | 10.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 22 | 22 | $709.80 | $341.48 | 48.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 15 | 19 | $520.98 | $147.18 | 28.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 12 | 17 | $544.00 | $80.47 | 14.8% |
About Dr. Robert Holley, MD
Dr. Robert Holley, MD is a Family Medicine healthcare provider based in Pt Pleasant, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295834810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Holley, MD has received a total of $4,206 in payments from pharmaceutical and medical device companies, with $501.28 received in 2022. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,165).
As a Medicare-enrolled provider, Holley has provided services to 1,130 Medicare beneficiaries, totaling 2,934 services with total Medicare billing of $187,736. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pt Pleasant, WV
- Active Since 09/21/2006
- Last Updated 08/16/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1295834810
Products in Payments
- TRELEGY ELLIPTA (Drug) $417.68
- SYMBICORT (Drug) $259.59
- Repatha (Biological) $257.48
- ANORO (Drug) $234.03
- Vascepa (Drug) $207.21
- BEVESPI AEROSPHERE (Drug) $200.43
- LOKELMA (Drug) $150.63
- ANORO ELLIPTA (Drug) $131.42
- Veltassa (Drug) $115.25
- FARXIGA (Drug) $114.05
- QULIPTA (Drug) $106.77
- VRAYLAR (Drug) $106.48
- ENTRESTO (Drug) $99.48
- SOLIQUA (Drug) $99.00
- Proclaim Family of SCS IPGs (Device) $77.27
- UBRELVY (Drug) $66.00
- JARDIANCE (Drug) $65.61
- LINZESS (Drug) $63.62
- TRULICITY (Drug) $63.27
- GEMTESA (Drug) $61.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.